Amneal acquires generic manufacturing plant, 18 generic products

PATERSON, N.J. Amneal Pharmaceuticals has completed the acquisition of a liquid-form generic pharmaceuticals manufacturing plant in Branchburg, N.J., as well as gaining the rights to 18 generic products.

This new plant, built in 2004 and equipped with the latest equipment and technology, has a production capacity of 7 million bottles per year of prescription liquids as well as more than 1 billion tablets/capsules per year of oral solids.

Of the 18 products acquired, one is approved, five have been submitted to the Food and Drug Administration, with approvals anticipated in the second quarter of 2008, while 12 products are in the development pipeline to be filed in 2008-09. The first product from this plant will begin shipping in February.

“This addition of an outstanding generic liquid pharmaceuticals manufacturing plant advances Amneal’s strategic plan and enables us to provide a broader offering to our customers. It nicely complements our oral solid capabilities as well as our ophthalmic category joint venture,” said Chirag Patel, Amneal’s president.